Products for Research Use Only
RegisterLogin

Berberine (chloride)

CAT: 0804-HY-18258-01Size: 5 gDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-18258-01Size:5 g
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Berberine chloride is an alkaloid that acts as an antibiotic. Berberine chloride induces reactive oxygen species (ROS) generation and inhibits DNA topoisomerase. Antineoplastic properties[1].
CAS Number
633-65-8
Product Name Alternative
Natural Yellow 18 (chloride)
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Antibiotic; Autophagy; Bacterial; Endogenous Metabolite; Parasite; Reactive Oxygen Species (ROS) ; Topoisomerase
Type
Natural Products
Related Pathways
Anti-infection; Autophagy; Cell Cycle/DNA Damage; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/Berberine-chloride.html
Purity
99.92
Solubility
DMSO : 8.33 mg/mL (ultrasonic) |H2O : < 0.1 mg/mL (ultrasonic)
Smiles
COC1=C(OC)C2=C[N+]3=C(C(C(CC3)=C4)=CC5=C4OCO5)C=C2C=C1.[Cl-]
Molecular Formula
C20H18ClNO4
Molecular Weight
371.81
Precautions
H302, H315, H319, H335
References & Citations
[1]Cai Y, et al. Berberine inhibits the growth of human colorectal adenocarcinoma in vitro and in vivo. J Nat Med. 2014 Jan;68 (1) :53-62.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Natural Products
Clinical Information
Launched
Citation 01
Acta Pharm Sin B. 2025 Jul 9.|Aquacult Nutr. 14 Jul 2022.|Biochem Pharmacol. 2021 Jun:188:114576.|Biochim Biophys Acta Mol Basis Dis. 2025 May 22:167920.|Cell Signal. 2025 Jul:131:111732.|Chin Med. 2025 Nov 17;20 (1) :190.|CNS Neurosci Ther. 2025 Feb;31 (2) :e70253.|Front Pharmacol. 2023 Apr 18:14:1148611.|Inflammopharmacology. 2024 May 17.|Int Immunopharmacol. 2024 May 29:136:112278.|Int Immunopharmacol. 2024 Sep 24;142 (Pt B) :113227.|Int J Biol Macromol. 2025 May 21:144496.|J Appl Toxicol. 2024 Nov;44 (11) :1700-1713.|J Food Biochem. 2025 Jul 16.|Mech Ageing Dev. 2020 Oct;191:111347.|Molecules. 2024 May 14.|Nat Commun. 2025 Jan 2;16 (1) :212.|Oncologie. 2023 Mar 10.|Phytomedicine. 2023 Sep:118:154962.|Phytomedicine. 2025 Apr:139:156517.|Research Square Preprint. 2021 May.|Research Square Print. 2022 Aug.|Acta Pharmacol Sin. 2023 Feb;44 (2) :332-344.|Appl Biochem Biotechnol. 2024 Aug;196 (8) :5265-5282.|Aquaculture. 15 May 2022, 738055.|Biol Pharm Bull. 2022 Oct 1;45 (10) :1444-1451.|Biomed Pharmacother. 2024 Jan:170:116012.|BMC Pharmacol Toxicol. 2023 May 11;24 (1) :29.|Cell Stem Cell. 2025 May 1;32 (5) :778-794.e10.|Evid Based Complement Alternat Med. 2021 May 4:2021:6688629.|Exp Cell Res. 2020 Aug 1;393 (1) :112054.|Exp Cell Res. 2024 May 13:114094.|Fish Shellfish Immunol. 2024 Jun:149:109522.|Food Chem Toxicol. 2023 May:175:113743.|Gene. 2022 Mar 30:816:146171.|Genome Instab Dis. 2025 Mar.|Hepatol Commun. 2024 Mar 29;8 (4) :e0405.|Int J Nanomedicine. 2023 Jul 31:18:4347-4363.|J Bone Miner Metab. 2021 Sep;39 (5) :748-756.|J Cell Mol Med. 2025 Sep;29 (17) :e70836.|J Ethnopharmacol. 2022 Mar 1:285:114786.|J Ethnopharmacol. 2024 Apr 24:324:117829.|J Inflamm Res. 2025 Aug 21:18:11451-11461.|J Pharm Pharmacol. 2022 Sep 1;74 (9) :1353-1363.|JCI Insight. 2023 Jul 24;8 (14) :e166306.|Microb Pathog. 2025 Dec:209:108114.|Mol Med Rep. 2023 Jan;27 (1) :17.|Mol Med. 2024 Dec 20;30 (1) :251.|Pharm Biol. 2024 Dec;62 (1) :53-61.|Phytomedicine. 2024 Jan:123:155247.|Phytomedicine. 2025 Sep 4:148:157233.|Res Sq. 2025 Apr 15.|Research Square Preprint. 2021 Jun.|Research Square Preprint. 2021 Sep.|Sci Rep. 2022 Oct 17;12 (1) :17350.|Sci Rep. 2025 Jul 1;15 (1) :21623.|SSRN. 2023 Jan 27.|Toxicol Appl Pharmacol. 2025 Sep 13:505:117563.|Toxicol In Vitro. 2025 Dec:109:106128.|Cardiovasc Drugs Ther. 2022 Aug;36 (4) :633-643.|J Appl Microbiol. 2021 Apr;130 (4) :1154-1172.|Microbiol Spectr. 2023 Sep 25;11 (5) :e0217023.|NPJ Biofilms Microbiomes. 2025 Jul 1;11 (1) :120.|NPJ Sci Food. 2025 Feb 4;9 (1) :16.|Int Immunopharmacol. 2024 May 30:133:112036.|Mol Reprod Dev. 2024 Aug;91 (8) :e23768.|NPJ Sci Food. 2025 Feb 4;9 (1) :16.

Related Products

CatalogName
HY-18258SBerberine-d6 (chloride)
HY-N0716Berberine
HY-N0716A-01Berberine (hemisulfate)
HY-147246-01Berberine ursodeoxycholate
HY-N0716B-01Berberine (sulfate)
HY-N0716BR-01Berberine (sulfate) (Standard)
HY-N0716AR-01Berberine (hemisulfate) (Standard)
HY-N6957-018-Keto-berberine
HY-W012954S-01TMA chloride-d12 (chloride)
HY-N8262Dehydrocorybulbine (chloride)

Alternative Products

CatalogName
217216Berberine Chloride (Berberine)
217215Berberine Chloride (Berberine) discontinued
BB0129Berberine chloride
TRC-B318150-100GBerberine Chloride Hydrate

Popular Products